Table 3 Comparison of adverse reaction rates between the two groups
Adverse Reaction [n (%)] | RCA-PE Group n = 45 | NM-PE Group n = 21 | P-value |
|---|---|---|---|
Total Adverse Reactions | 29 (64.4) | 5 (23.8) | 0.003 |
Bleeding Events | 2 (4.4) | 1 (4.8) | > 0.999 |
Metabolic Alkalosis | 22 (48.9) | 1 (4.8) | < 0.001 |
Severe Metabolic Alkalosisa | 7(15.6) | 0(0) | - |
Hypocalcemia | 2 (4.4) | 1 (4.8) | > 0.999 |
Hypercalcemia | 0(0) | 0(0) | - |
Lactic Acidosis | 2 (4.4) | 1 (4.8) | > 0.999 |
Hyperkalemia | 1 (2.2) | 1 (4.8) | 0.538 |
Hypernatremia | 0(0) | 0(0) | - |
Hyponatremia | 0(0) | 0(0) | - |